» Articles » PMID: 10985231

Unit-treatment Interaction and Its Practical Consequences

Overview
Journal Biometrics
Specialty Public Health
Date 2000 Sep 14
PMID 10985231
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Most statistical characterizations of a treatment effect focus on the average effect of the treatment over an entire population. However, average effects may provide inadequate information, sometimes misleading information, when a substantial unit-treatment interaction is present in the population. It is even possible that a nonnegligible proportion of the individuals in the population experience an unfavorable treatment effect even though the treatment might appear to be beneficial when considering population averages. This paper examines the extent to which information about unit-treatment interaction can be extracted using observed data from a two-treatment completely randomized experiment. A method for utilizing the information from an available covariate is proposed. Although unit-treatment interaction is a nonidentifiable quantity, we show that mathematical bounds for it can be estimated from observed data. These bounds lead to estimated bounds for the probability of an unfavorable treatment effect. Maximum likelihood estimators of the bounds and their corresponding large-sample distributions are given. The use of the estimated bounds is illustrated in a clinical trials data example.

Citing Articles

Design, analysis, and interpretation of treatment response heterogeneity in personalized nutrition and obesity treatment research.

Zoh R, Esteves B, Yu X, Fairchild A, Vazquez A, Chapple A Obes Rev. 2023; 24(12):e13635.

PMID: 37667550 PMC: 10825777. DOI: 10.1111/obr.13635.


Causal models and causal modelling in obesity: foundations, methods and evidence.

Zoh R, Yu X, Dawid P, Davey Smith G, French S, Allison D Philos Trans R Soc Lond B Biol Sci. 2023; 378(1888):20220227.

PMID: 37661742 PMC: 10475873. DOI: 10.1098/rstb.2022.0227.


The Use of Covariates and Random Effects in Evaluating Predictive Biomarkers Under a Potential Outcome Framework.

Zhang Z, Nie L, Soon G, Liu A Ann Appl Stat. 2016; 8(4):2336-2355.

PMID: 26779295 PMC: 4714717. DOI: 10.1214/14-AOAS773.


Assessing the heterogeneity of treatment effects via potential outcomes of individual patients.

Zhang Z, Wang C, Nie L, Soon G J R Stat Soc Ser C Appl Stat. 2014; 62(5):687-704.

PMID: 25506088 PMC: 4261197. DOI: 10.1111/rssc.12012.


Treatment benefit and treatment harm rate to characterize heterogeneity in treatment effect.

Shen C, Jeong J, Li X, Chen P, Buxton A Biometrics. 2013; 69(3):724-31.

PMID: 23865447 PMC: 3787989. DOI: 10.1111/biom.12038.